Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|May 28, 2011
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's diseaseJ Panés, R Bouzas, M Chaparro, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationJ Molina-Infante, B Perez-Gallardo, M Fernandez-Bermejo, et al.
The American Journal of Gastroenterology|May 15, 2019
Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic CancersMíriam Mañosa, M Chaparro, A Juan, et al.
Journal of Crohn'S & Colitis|July 24, 2014
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)C Loras, J P Gisbert, M C Saro, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2012
Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failuresJ P Gisbert, M Castro-Fernandez, A Perez-Aisa, et al.
Revista Clinica Espanola|December 9, 2000
[Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease]F Bermejo San José, D Boixeda de Miguel, J P Gisbert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2002
Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?J P Gisbert, A I Cruzado, L M Benito, et al.
Revista Espanola De Enfermedades Digestivas|May 23, 2003
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatmentJ P Gisbert, J Ducons, F Gomollón, et al.
Scandinavian Journal of Gastroenterology|January 11, 2012
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trialA Barbero-Villares, J Mendoza Jiménez-Ridruejo, C Taxonera, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2011
The changing face of hospitalisation due to gastrointestinal bleeding and perforationA Lanas, L A García-Rodríguez, M Polo-Tomás, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|May 28, 2011
Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's diseaseJ Panés, R Bouzas, M Chaparro, et al.
Alimentary Pharmacology & Therapeutics|February 26, 2010
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradicationJ Molina-Infante, B Perez-Gallardo, M Fernandez-Bermejo, et al.
The American Journal of Gastroenterology|May 15, 2019
Immunomodulatory Therapy Does Not Increase the Risk of Cancer in Persons With Inflammatory Bowel Disease and a History of Extracolonic CancersMíriam Mañosa, M Chaparro, A Juan, et al.
Journal of Crohn'S & Colitis|July 24, 2014
Impact of surveillance of hepatitis b and hepatitis c in patients with inflammatory bowel disease under anti-TNF therapies: multicenter prospective observational study (REPENTINA 3)C Loras, J P Gisbert, M C Saro, et al.
Alimentary Pharmacology & Therapeutics|March 1, 2012
Fourth-line rescue therapy with rifabutin in patients with three Helicobacter pylori eradication failuresJ P Gisbert, M Castro-Fernandez, A Perez-Aisa, et al.
Revista Clinica Espanola|December 9, 2000
[Efficacy of four widely used techniques of the diagnosis of Helicobacter pylori infection in gastric ulcer disease]F Bermejo San José, D Boixeda de Miguel, J P Gisbert, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 31, 2002
Helicobacter pylori "test-and-scope" strategy for dyspeptic patients. Is it useful and safe?J P Gisbert, A I Cruzado, L M Benito, et al.
Revista Espanola De Enfermedades Digestivas|May 23, 2003
Validation of the 13c-urea breath test for the initial diagnosis of helicobacter pylori infection and to confirm eradication after treatmentJ P Gisbert, J Ducons, F Gomollón, et al.
Scandinavian Journal of Gastroenterology|January 11, 2012
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trialA Barbero-Villares, J Mendoza Jiménez-Ridruejo, C Taxonera, et al.
Alimentary Pharmacology & Therapeutics|January 6, 2011
The changing face of hospitalisation due to gastrointestinal bleeding and perforationA Lanas, L A García-Rodríguez, M Polo-Tomás, et al.
Pageof 32